Newsroom

Sorted by: Latest
-

A Concept Medical anuncia a inclusão do primeiro paciente no estudo clínico randomizado STARS DAPT, que avalia o stent farmacológico sem polímero Abluminus NP

TAMPA, Flórida--(BUSINESS WIRE)--A Concept Medical Inc., pioneira global em tecnologia inovadora de administração de medicamentos, tem o orgulho de anunciar a inclusão bem-sucedida do primeiro paciente no estudo clínico randomizado e controlado STARS DAPT (ST-Infarto do miocárdio com elevação do segmento ST tratado com um stent farmacológico sem polímero, com liberação de sirolimus por nanocarreador, e uma estratégia de terapia antiplaquetária única baseada em inibidor de P2Y12 após um curto pe...
-

Concept Medical inscribe los primeros pacientes en el ensayo clínico aleatorizado STARS DAPT, que evalúa el stent liberador de medicamentos sin polímeros Abluminus np

TAMPA, Florida--(BUSINESS WIRE)--Concept Medical Inc., pionera mundial en tecnología innovadora para la administración de medicamentos, se enorgullece de anunciar la incorporación satisfactoria de los primeros pacientes al estudio STARS DAPT ( ST -Segment Elevation Myocardial Inf A rction treated with a Polymer-Free Sirolimus-based Nanocarrie R Eluting Stent and a P2Y12 inhibitor-based S ingle Antiplatelet Strategy after a Short Dual Antiplatelet Therapy versus conventional D ual A nti P latele...
-

Samenvatting: Concept Medical kondigt de registratie aan van de eerste patiënten in de STARS DAPT gerandomiseerde klinische studie waarin Abluminus NP polymeervrije DES wordt beoordeeld

TAMPA, Fla.--(BUSINESS WIRE)--Concept Medical Inc., een wereldwijde pionier in innovatieve technologie voor toediening van geneesmiddelen, kondigt trots de succesvolle registratie aan van de eerste patiënten in de STARS DAPT ( ST -Segment Elevation Myocardial Inf A rction (= myocardinfarct met ST-segmentstijging) behandeld met een polymeervrije, op sirolimus gebaseerde nanocarrie R eluting stent en een op P2Y12 remmer gebaseerde S ingle Antiplatelet Strategie na een korte Dual Antiplatelet Ther...
-

Concept Medical kündigt die erste Patientenaufnahme in die randomisierte klinische Studie STARS DAPT zur Bewertung des Abluminus NP polymerefreien DES an

TAMPA, Florida--(BUSINESS WIRE)--Concept Medical Inc., ein globaler Pionier auf dem Gebiet innovativer Wirkstofffreisetzungstechnologien, freut sich, die erfolgreiche Aufnahme der ersten Patienten in die randomisierte kontrollierte STARS DAPT ( ST -Segment Elevation Myocardial Inf A rction treated with a Polymer-Free Sirolimus-based Nanocarrie R Eluting Stent and a P2Y12 inhibitor-based S ingle Antiplatelet Strategy after a Short Dual Antiplatelet Therapy versus conventional D ual A nti P latel...
-

Concept Medical annonce le recrutement du premier patient dans l'essai clinique randomisé STARS DAPT qui évalue l'Abluminus np, un DES sans polymère

TAMPA, Floride--(BUSINESS WIRE)--Concept Medical Inc., un pionnier mondial dans la technologie innovante d'administration de médicaments, est fier d'annoncer l'inscription des premiers patients dans l'essai contrôlé randomisé STARS DAPT ( ST -Segment Elevation Myocardial Inf A rction treated with a Polymer-Free Sirolimus-based Nanocarrie R Eluting Stent and a P2Y12 inhibitor-based S ingle Antiplatelet Strategy after a Short Dual Antiplatelet Therapy versus conventional D ual A nti P latelet T h...
-

Riassunto: Concept Medical annuncia l'arruolamento del primo paziente in STARS DAPT, il trial clinico randomizzato di valutazione del DES senza polimeri Abluminus NP

TAMPA, Fla.--(BUSINESS WIRE)--Concept Medical Inc., un pioniere globale nella tecnologia innovativa del rilascio di farmaci, è lieta di annunciare il reclutamento dei primi pazienti nello studio clinico randomizzato controllato STARS DAPT ( ST -Segment Elevation Myocardial Inf A rction treated with a Polymer-Free Sirolimus-based Nanocarrie R Eluting Stent and a P2Y12 inhibitor-based S ingle Antiplatelet Strategy after a Short Dual Antiplatelet Therapy versus conventional D ual A nti P latelet T...
-

コンセプト・メディカル、Abluminus NPポリマーフリーDESを評価するSTARS DAPT無作為化臨床試験で初の患者登録を達成

フロリダ州タンパ--(BUSINESS WIRE)--（ビジネスワイヤ） -- 革新的なドラッグデリバリー技術を手がける世界的なパイオニアであるコンセプト・メディカル（Concept Medical Inc.）は、無作為化比較試験「STARS DAPT（ ST -Segment Elevation Myocardial Inf A rction treated with a Polymer-Free Sirolimus-based Nanocarrie R Eluting Stent and a P2Y12 inhibitor-based S ingle Antiplatelet Strategy after a Short Dual Antiplatelet Therapy versus conventional D ual A nti P latelet T herapy）（ポリマーフリーのシロリムス系ナノキャリア溶出ステントで治療したST上昇型心筋梗塞（STEMI）患者を対象に、短期の抗血小板薬2剤併用療法後にP2Y12阻害薬を用いた単剤抗血小板療法と従来の抗血小板薬2剤併用療...
-

Port of Los Angeles Selects Pacific Cruise Terminals, LLC as Developer and Operator of Two Cruise Centers

LOS ANGELES--(BUSINESS WIRE)--Port of Los Angeles Selects Pacific Cruise Terminals, LLC as Developer and Operator of Two Cruise Centers...
-

Concept Medical宣布评估Abluminus NP无聚合物药物洗脱支架的STARS DAPT随机临床试验完成首例患者入组

佛罗里达州坦帕--(BUSINESS WIRE)--(美国商业资讯)-- 创新药物递送技术领域的全球先驱企业Concept Medical Inc.自豪地宣布，STARS DAPT随机对照试验已成功完成首例患者入组。该试验全称为ST段抬高型心肌梗死患者接受无聚合物西罗莫司纳米载体洗脱支架治疗，且在短期双联抗血小板治疗后采用P2Y12抑制剂单联抗血小板策略对比传统双联抗血小板治疗的研究( ST -Segment Elevation Myocardial Inf A rction treated with a Polymer-Free Sirolimus-based Nanocarrie R Eluting Stent and a P2Y12 inhibitor-based S ingle Antiplatelet Strategy after a Short Dual Antiplatelet Therapy versus conventional D ual A nti P latelet T herapy)，标志着评估无聚合物药物洗脱支架(DES)这一突破性技术用于治疗ST段抬高型心...
-

Concept Medical宣布評估Abluminus NP無聚合物藥物洗脫支架的STARS DAPT隨機臨床試驗完成首例病患招募

佛羅里達州坦帕--(BUSINESS WIRE)--(美國商業資訊)-- 創新藥物遞送技術領域的全球先驅Concept Medical Inc.驕傲地宣布，STARS DAPT隨機對照試驗已成功完成首例病患招募。該試驗全稱為ST段抬高型心肌梗死病患接受無聚合物西羅莫司奈米載體洗脫支架治療，且在短期雙聯抗血小板治療後採用P2Y12抑制劑單聯抗血小板策略對比傳統雙聯抗血小板治療的研究( ST -Segment Elevation Myocardial Inf A rction treated with a Polymer-Free Sirolimus-based Nanocarrie R Eluting Stent and a P2Y12 inhibitor-based S ingle Antiplatelet Strategy after a Short Dual Antiplatelet Therapy versus conventional D ual A nti P latelet T herapy)，代表評估無聚合物藥物洗脫支架(DES)這一突破性技術用於治療ST段抬高型心肌梗死...